Aurisco Pharmaceutical Co.,Ltd is an API manufacturer based in China. It holds 38 active US drug master files across a filed portfolio of 17 molecules. Its GMP standing is certified by MFDS (Korea).
| Molecule | Regulators | Docs |
|---|---|---|
| Flumethasone | US FDA | 4 |
| Fluticasone Propionate | US FDA | 4 |
| Abiraterone | SFDA (Saudi Arabia), US FDA | 3 |
| Apalutamide | US FDA | 2 |
| Betamethasone | US FDA | 2 |
| Brivaracetam | US FDA | 2 |
| Budesonide | US FDA | 2 |
| Darolutamide | US FDA | 2 |
| Enzalutamide | US FDA | 2 |
| Eplerenone | US FDA | 2 |
| Finerenone | US FDA | 2 |
| Fluticasone Furoate | US FDA | 2 |
| Mometasone Furoate | US FDA | 2 |
| Pregabalin | US FDA | 2 |
| Relugolix | US FDA | 2 |
| Tenofovir Alafenamide | US FDA | 2 |
| Tenofovir Disoproxil | US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 6 | None |
| MFDS (Korea) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Aurisco Pharmaceutical Co.,Ltd comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.